Correlation Between Beam Therapeutics and Nurix Therapeutics

Can any of the company-specific risk be diversified away by investing in both Beam Therapeutics and Nurix Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Beam Therapeutics and Nurix Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Beam Therapeutics and Nurix Therapeutics, you can compare the effects of market volatilities on Beam Therapeutics and Nurix Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Beam Therapeutics with a short position of Nurix Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Beam Therapeutics and Nurix Therapeutics.

Diversification Opportunities for Beam Therapeutics and Nurix Therapeutics

0.2

Correlation Coefficient

Beam Therapeutics  Nurix Therapeutics

Modest diversification

The 3 months correlation between Beam and Nurix is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding Beam Therapeutics and Nurix Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nurix Therapeutics and Beam Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Beam Therapeutics are associated (or correlated) with Nurix Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nurix Therapeutics has no effect on the direction of Beam Therapeutics i.e., Beam Therapeutics and Nurix Therapeutics go up and down completely randomly.

Pair Corralation between Beam Therapeutics and Nurix Therapeutics

Given the investment horizon of 90 days Beam Therapeutics is expected to generate 1.25 times more return on investment than Nurix Therapeutics. However, Beam Therapeutics is 1.25 times more volatile than Nurix Therapeutics. It trades about -0.05 of its potential returns per unit of risk. Nurix Therapeutics is currently generating about -0.17 per unit of risk. If you would invest  2,659  in Beam Therapeutics on December 27, 2024 and sell it today you would lose (468.00) from holding Beam Therapeutics or give up 17.6% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Beam Therapeutics  vs.  Nurix Therapeutics

Beam Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Beam Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Nurix Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Nurix Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's forward indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Beam Therapeutics and Nurix Therapeutics

The main advantage of trading using opposite Beam Therapeutics and Nurix Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Beam Therapeutics position performs unexpectedly, Nurix Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nurix Therapeutics will offset losses from the drop in Nurix Therapeutics' long position.

The idea behind Beam Therapeutics and Nurix Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.